Evaluation of Health Related Quality of Life via Computer-based Health Evaluation System (CHES) For Japanese Metastatic Breast Cancer Patients: A Pilot Study of Single Institution

Evaluation of Health Related Quality of Life via Computer-based Health Evaluation System (CHES) For Japanese Metastatic Breast Cancer Patients: A Pilot Study of Single Institution - CHES Pilot Study for Japanese Metastatic Breast Cancer Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023250

Enrollment

Registered

2016-09-01

Start date

2016-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metastatic breast cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Written informed consent, with the understanding that the patient may withdraw consent at any time without prejudice 2) Patients with metastatic breast cancer. 3) Patients who are treated with chemotherapy and endocrine therapy. 4) Patients who have tablet phone or PC in home. 5) Patients with expected survival for more than 6 months.

Exclusion criteria

Exclusion criteria: Patients considered to be inappropriate for the study participation, as judged by the primary physician.

Design outcomes

Primary

Measure	Time frame
Collection rate of questionnaire [The collected number of questionnaire / the planned number of questionnaire]	—

Secondary

Measure	Time frame
1)Time to deterioration 2)Rate of patients who show a minimally important difference score [Time to deterioration is defined as the time until clinically meaningful deterioration by a specified MID values is observed] [Literature-based threshold values for MID will be used for scales in the EORTC QLQ-C30]	—

Countries

Japan

Contacts

Public ContactYuichiro Kikawa

Kobe Medical Center General Hospital Department of Breast Surgery

u-1ro@kcho.jp0783024321

Outcome results